We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
30 hedge funds and large institutions have $5.66M invested in CASI Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
11% more funds holding
Funds holding: 27 → 30 (+3)
2% less capital invested
Capital invested by funds: $5.8M → $5.66M (-$138K)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
30
Holders Change
+3
Holders Change %
+11.11%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$188K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$25.2K |
| 3 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$16.9K |
| 4 |
EHC
Everett Harris & Co
Los Angeles,
California
|
+$16.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.41K |
Top Sellers
| 1 |
WSCM
Wellington Shields Capital Management
New York
|
-$81.6K |
| 2 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$27K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.68K |
| 4 |
EEG
E.E. Geduld
|
-$8.46K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$8K |
